Category - New Drugs
FDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled on Oral Antidiabetic Medicines
FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
FDA Approves Gloperba (colchicine) for Prophylaxis of Adult Gout Flares
FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
FDA Approves Esperoct (turoctocog alfa pegol, N8-GP) for Hemophilia A
FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
FDA Approves Egaten (triclabendazole) for the Treatment of Fascioliasis, a Neglected Tropical Disease
FDA Approves Darzalex (daratumumab) Split-Dosing Regimen